Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DR10624 in Moderate Hypertriglyceridemia and Diabetic Kidney Disease
NCT07848880Phase 2Not yet recruiting
- Sponsor
- Doer Bio
- Start
- Oct 2026
- Primary completion
- Apr 2028
- Countries
- 1
01
Overview
A Phase 2 trial of DR10624 in hypertriglyceridemia, diabetic kidney disease (DKD), sponsored by Doer Bio. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
DR10624
03
Conditions
hypertriglyceridemiadiabetic kidney disease (DKD)
Beyond the preview
Go deeper on NCT07848880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07848880.